Nine Monthly Results Results Snapshot
Figures in Rs cr
Standalone Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 12.15% vs 15.40% in Dec 2023
Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is -11.46% vs 29.90% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 24.88% vs 23.80% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is 41.94% vs 19.23% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of RPG LifeScience. With
Figures in Rs cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
510.34
7,329.57
-6,819.23
-93.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
510.34
7,329.57
-6,819.23
-93.04%
Raw Material Cost
83.37
566.08
-482.71
-85.27%
Purchase of Finished goods
73.92
1,433.87
-1,359.95
-94.84%
(Increase) / Decrease In Stocks
8.00
49.31
-41.31
-83.78%
Employee Cost
94.54
1,569.75
-1,475.21
-93.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
116.35
1,645.40
-1,529.05
-92.93%
Total Expenditure (Excl Depreciation)
376.18
5,264.41
-4,888.23
-92.85%
Operating Profit (PBDIT) excl Other Income
134.16
2,065.16
-1,931.00
-93.50%
Other Income
7.62
270.41
-262.79
-97.18%
Operating Profit (PBDIT)
141.78
2,335.57
-2,193.79
-93.93%
Interest
0.44
207.65
-207.21
-99.79%
Exceptional Items
-27.30
61.23
-88.53
-144.59%
Gross Profit (PBDT)
114.04
2,127.92
-2,013.88
-94.64%
Depreciation
16.06
255.85
-239.79
-93.72%
Profit Before Tax
97.98
1,872.07
-1,774.09
-94.77%
Tax
32.09
369.00
-336.91
-91.30%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
65.89
1,503.07
-1,437.18
-95.62%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
65.89
1,564.30
-1,498.41
-95.79%
Equity Capital
13.23
40.06
-26.83
-66.97%
Face Value
8.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
26.29%
28.18%
0.00
-1.89%
Gross Profit Margin
22.35%
29.03%
0.00
-6.68%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 510.34 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 12.15% vs 15.40% in Dec 2023
Nine Monthly - Standalone Net Profit
Standalone Net Profit 65.89 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -11.46% vs 29.90% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 134.16 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 24.88% vs 23.80% in Dec 2023
Nine Monthly - Interest
Interest 0.44 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 41.94% vs 19.23% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.29%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
